The vision of Life Science Leader is to be an essential business tool for life science executives. Our content is designed to not only inform readers of best practices, but motivate them to implement those best practices in their own businesses.
Issue link: https://lifescienceleadermag.epubxp.com/i/85321
Norwich Pharmaceuticals Norwich, NY www.norwichpharma.com (888) 674-7979 DRUG TYPE: Pharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – clinical (phase 2 and phase 3) Formulated Drug Production – dosage form development, dosage form production, and packaging SERVICES OFFERED: Capsules, controlled substances, cytotoxic & high-potency compounds, generics, non-sterile, OTC, semisolids, soft gels, solid dose, and sustained release. "At Norwich, we have dedicated ourselves to focus on our customers and the patients they serve. We understand that CMO Leadership Award recognition is directly tied to the success of our customers, and we are proud to be a reliable partner for all stages of the product life cycle from product development to scale-up and commercial manufacturing through clinical services. Patients put trust into our customers' products, and Norwich's 125-year history of quality and compliance provides a foundation for that trust." — Terry Novak, president DRUG TYPE: Pharmaceuticals and Biopharmaceuticals OSO BioPharmaceuticals Manufacturing, LLC Albuquerque, NM www.osobio.com (505) 923-2112 Manufacturing location: Albuquerque, NM Contact: Kristin Calloway Kristin.calloway@osobio.com DRUG LIFE CYCLE STAGES: Formulated Drug Production – dosage form production and packaging SERVICES OFFERED: Aseptic fill/finish, controlled substances, cytotoxic & high-potency compounds, generics, injectables, liquids, lyophilized products, parenterals (small volume), peptides, proteins, solutions & suspensions, sterile, syringes (pre-filled), and vaccines. "We are very pleased at OsoBio to have been recognized as a leading CMO in the categories for productivity and regulatory. We believe a strong commitment to regulatory compliance is the cornerstone to productivity. Our site history reveals a demonstrated track record of regulatory success, having been inspected by almost every worldwide regulatory agency in the commercialization of more than 250 distinct product codes. We are honored this commitment is recognized by our industry peers." — Milton Boyer, president DRUG LIFE CYCLE STAGES: Research & Development – discovery, pre-clinical, & clinical (phase 1, phase 2, & phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development and dosage form production SERVICES OFFERED: Aseptic fill/finish, generics, GMP manufacturing of biopharmaceuticals (including vaccines), injectables, liquids, process development, proteins, research services, sterile, and vaccines. "With more than 20 years in business, Paragon's associates provide decades of collective experience working with biologics — from our scientists and engineers to our project managers, quality and regulatory personnel. We're very proud of that. Also, fueled by ongoing consolidation in the pharmaceutical industry, the demand for Paragon's areas of expertise (development of biopharmaceuticals — including recombinant proteins, viral vectors and vaccines) is expected to continue to increase in double digits for years to come." — Marco A. Chacón, Ph.D., president & CEO The CMO Leadership Awards 2012 43 Manufacturing location: Norwich, NY Contact: Stephanie Ferrell stephanie.ferrell@norwichpharma.com DRUG TYPE: Pharmaceuticals and Biopharmaceuticals DRUG LIFE CYCLE STAGES: Research & Development – pre-clinical and clinical (phase 1, phase 2, and phase 3) Drug Substance Production – primary process development and drug substance production Formulated Drug Production – dosage form development, dosage form production, packaging, and logistics SERVICES OFFERED: Aseptic fill/finish, controlled substances, cytotoxic & high potency compounds, downstream processing , generics, injectables, lyophilized products, non-sterile, peptides, powders (non-sterile), powders (sterile), purification, proteins, solutions & suspensions, sterile, and vaccines. "The need for better and safer products, particularly in life-science industries, commands ever purer and more complex molecules. Novasep's unique offerings, which include contract manufacturing services and the supply of purification technologies, enables us to develop and implement cost-effective and sustainable solutions for the production of synthetic and biomolecules at the required purity. Furthermore, I believe that our commitment to the projects of our customers is key in building fruitful and durable relationships with them." — Roger-Marc Nicoud, CEO DRUG TYPE: Biopharmaceuticals Paragon Bioservices, Inc. Baltimore, MD www.paragonbioservices.com www.twitter.com/paragonbio (410) 975-4050/(800) 545-6569 Manufacturing location: Baltimore, MD Philip W. Wills, Ph.D. pwills@paragonbioservices.com NOVASEP Pompey, France www.novasep.com + 33 3 83 49 71 00 Manufacturing locations: Belgium, France, and Germany Contact: Michel Blanc m ichel.blanc@novasep.com DRUG LIFE CYCLE STAGES